The expanding benefits of GLP-1 medicines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40669447.
- Also identified by DOI 10.1016/j.xcrm.2025.102214 and PMC identifier 12281309.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GLP-1 medicines, initially developed for blood glucose and weight control, improve outcomes in people with cardiovascular, kidney, liver, arthritis, and sleep apnea disorders, actions mediated in part through anti-inflammatory and metabolic pathways, with some benefits partly independent of the degree of weight loss achieved.
Medical subject headings
- Glucagon-Like Peptide 1
- Hypoglycemic Agents